Les syndromes paranéoplasiques

Area of Science:

• Neurology
• Oncology
• Immunology

Background:

• Paraneoplastic syndromes are rare neurological complications of systemic cancer.
• Neurologic symptoms often precede cancer diagnosis, affecting various nervous system parts.
• These syndromes can impact the cerebral cortex, cerebellum, spinal cord, peripheral nerves, neuromuscular junction, or muscle.

Purpose of the Study:

• To elucidate the pathogenesis, diagnosis, and treatment of paraneoplastic syndromes affecting the nervous system.

Main Methods:

• Review of current understanding of paraneoplastic syndrome pathogenesis.
• Diagnostic criteria including preceding neurologic disorder and autoantibody identification.
• Treatment strategies involving cancer management and immunosuppression.

Main Results:

• The pathogenesis is immune-mediated, with the immune system targeting neuronal antigens expressed by cancer cells.
• Diagnosis relies on identifying an underlying cancer in patients with unexplained neurological deficits or detecting specific autoantibodies.
• Treatment requires addressing the primary cancer and employing immunosuppressive therapies.

Conclusions:

• Paraneoplastic neurological syndromes result from an autoimmune response triggered by cancer.
• Early diagnosis through neurological assessment and serological testing is crucial.
• Integrated treatment of the underlying malignancy and immunosuppression offers the best management approach.